Review
Pharmacological treatment of exertional dyspnoea in stable COPD patients
Affiliations
- PMID: 9401366
Item in Clipboard
Review
Pharmacological treatment of exertional dyspnoea in stable COPD patients
Monaldi Arch Chest Dis.
1997 Aug.
Abstract
Exertional dyspnoea is one of the most common and disabling symptoms in patients with stable chronic obstructive pulmonary disease (COPD). Because little can be done for its resolution, the idea of its symptomatic treatment is attractive. There is no gold standard for the pharmacological management of exertional dyspnoea in stable COPD. A reassessment of the available literature shows the current perspectives and limits.
Similar articles
-
Four-week nebulized beclomethasone dipropionate in stable COPD patients with exertional dyspnoea.Monaldi Arch Chest Dis. 1999 Jun;54(3):224-7. Monaldi Arch Chest Dis. 1999. PMID: 10441974 Clinical Trial.
-
Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.Respir Med. 2011 Sep;105(9):1345-51. doi: 10.1016/j.rmed.2011.03.013. Epub 2011 Apr 8. Respir Med. 2011. PMID: 21482091 Clinical Trial.
-
Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.Thorax. 2009 Mar;64(3):216-23. doi: 10.1136/thx.2008.103598. Epub 2008 Dec 3. Thorax. 2009. PMID: 19052054 Clinical Trial.
-
Dyspnoea in chronic obstructive pulmonary disease.Monaldi Arch Chest Dis. 1998 Dec;53(6):669-71. Monaldi Arch Chest Dis. 1998. PMID: 10063342 Review. No abstract available.
-
Pharmacological treatment of exercise dyspnoea.Monaldi Arch Chest Dis. 2001 Feb;56(1):43-7. Monaldi Arch Chest Dis. 2001. PMID: 11407209 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical